Page URL:

The eyes have it: gene therapy delivered to retina in mice

17 June 2013
Appeared in BioNews 709

A 'non-invasive' method for delivering gene therapy into the eye has been developed by US researchers.

The team found that a version of the gene therapy vector adeno-associated virus (AAV) successfully delivered genes to the retina in mice after being injected into the gel-like core of the eye, known as the vitreous humour.

This is less invasive than the current method, where AAVs are injected directly into the retina, and therefore potentially safer.

'Sticking a needle through the retina and injecting the engineered virus behind the retina is a risky surgical procedure', said Professor David Schaffer, director of the Berkeley Stem Cell Center, who led the study. 'Building upon 14 years of research, we have now created a virus that you just inject into the liquid vitreous humor inside the eye, and it delivers genes to a very difficult-to-reach population of delicate cells in a way that is surgically non-invasive and safe'.

Previously, delivering gene therapy into the retina posed a challenge as AAVs are evolved to infect lung cells rather than penetrating tissue. To bioengineer AAV into a form that could migrate to, and penetrate, the retina, the Berkeley team used a technique known as directed evolution.

Directed evolution involved injecting millions of AAVs into the vitreous humour of mouse eyes and selecting only those AAVs that reached retinal cells. Researchers collected these 'successful' vectors, replicated them and repeated the process. This selected the virus particles best adapted to reach and penetrate the retina. After six cycles, the research group sequenced the genomes of the final AAV vectors collected.

Around two-thirds of the evolved AAV vectors were of the same type, which the researchers named 7m8. In mice with hereditary blindness, 7m8 successfully introduced corrective genes to the retina. However, when tested on macaques, vector uptake was patchy, as primates have thicker retinas than mice, but the team hope that further directed evolution may improve uptake.

This method shows promise as a treatment for some forms of hereditary blindness, and could expand the scope of gene therapy. Professor Shaffer predicts these enhanced AAVs could also knock out genes that actively kill retina cells.

Helen May, optometrist and eye health advisor for the Royal National Institute for the Blind, told the Daily Express: 'Clearly it is still at an early stage and more extensive trials are needed to confirm the safety and effectiveness of this kind of treatment'.

Genes Get in Your Eye
The Scientist |  12 June 2013
In Vivo–Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous
Science Translational Medicine |  12 June 2013
Researchers develop easy and effective therapy to restore sight
UC Berkeley (press release) |  12 June 2013
Virus That Evolved in the Lab Delivers Gene Therapy into the Retina
MIT Technology Review |  12 June 2013
Wonder jab 'can cure blindness'
Daily Express |  14 June 2013
16 June 2014 - by Alice Plein 
In a research first, a section of light-sensing tissue, closely resembling the human retina, has been grown in the laboratory from human stem cells...
28 April 2014 - by Ruth Retassie 
Gene therapy, performed using cochlear implants, has regenerated auditory nerves in guinea pigs, a study reports...
16 January 2014 - by Siobhan Chan 
Gene therapy for an eye condition called choroideremia is safe and has improved the vision of six patients, says a study in the Lancet...
11 February 2013 - by Reuben Harwood 
A short strip of genetic material has been used to prevent hereditary deafness in mice...
10 September 2012 - by Holly Rogers 
Scientists have restored the sense of smell in mice using a gene therapy designed to repair the cilia - hair-like formations on nasal cells that are important in olfaction...
12 March 2012 - by Dr Nadeem Shaikh 
A potential stem cell therapy for glaucoma – a degenerative eye condition that can lead to blindness – has yielded positive results in animal tests...
31 January 2012 - by Rosemary Paxman 
A clinical trial testing the safety of using human embryonic stem cell (hESC) in the treatment of progressive eye conditions has been carried out by researchers in the USA...
31 October 2011 - by Victoria Kay 
A British man has become the first person to receive an advanced gene therapy treatment in a bid to save his sight. Jonathan Wyatt, aged 63, is the first of 12 patients to have the experimental procedure to try and halt the progression of his genetic eye disorder, choroideraemia. While he still has some sight, if left untreated, he would eventually become blind...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.